scholarly journals Phase I/II CANON study: oncolytic immunotherapy for the treatment of non-muscle invasive bladder (NMIBC) cancer using intravesical coxsackievirus A21

2016 ◽  
Vol 27 ◽  
pp. vi361 ◽  
Author(s):  
H.S. Pandha ◽  
N. Annels ◽  
M. Arif ◽  
H. Mostafid ◽  
S. Sandhu ◽  
...  
Keyword(s):  
Phase I ◽  
Coxsackievirus A21 ◽  
Oncolytic Immunotherapy ◽  
Muscle Invasive

Phase I/II canon study: Oncolytic immunotherapy for the treatment of non-muscle invasive bladder (NMIBC) cancer using intravesical coxsackievirus A21.

2016 ◽  
Vol 34 (15_suppl) ◽  
pp. e16016-e16016 ◽  
Author(s):  
Hardev S. Pandha ◽  
Nicola E. Annels ◽  
Guy Simpson ◽  
Hugh Mostafid ◽  
Kevin J. Harrington ◽  
...  
Keyword(s):  
Phase I ◽  
Coxsackievirus A21 ◽  
Oncolytic Immunotherapy ◽  
Muscle Invasive

scholarly journals Phase I/II storm study: Intravenous delivery of a novel oncolytic immunotherapy agent, Coxsackievirus A21, in advanced cancer patients

2015 ◽  
Vol 3 (Suppl 2) ◽  
pp. P341 ◽  
Author(s):  
Hardev Pandha ◽  
Kevin Harrington ◽  
Christy Ralph ◽  
Alan Melcher ◽  
Mark Grose ◽  
...  
Keyword(s):  
Phase I ◽  
Cancer Patients ◽  
Advanced Cancer ◽  
Advanced Cancer Patients ◽  
Coxsackievirus A21 ◽  
Oncolytic Immunotherapy

scholarly journals Phase I Trial of an ICAM-1-Targeted Immunotherapeutic-Coxsackievirus A21 (CVA21) as an Oncolytic Agent Against Non Muscle-Invasive Bladder Cancer

2019 ◽  
Vol 25 (19) ◽  
pp. 5818-5831 ◽  
Author(s):  
Nicola E. Annels ◽  
David Mansfield ◽  
Mehreen Arif ◽  
Carmen Ballesteros-Merino ◽  
Guy R. Simpson ◽  
...  
Keyword(s):  
Bladder Cancer ◽  
Phase I ◽  
Phase I Trial ◽  
Invasive Bladder Cancer ◽  
Muscle Invasive Bladder Cancer ◽  
Coxsackievirus A21 ◽  
Muscle Invasive
Sign in / Sign up

Export Citation Format

Share Document